News summary

PCOS/PMOS Increases Alzheimer’s Risk

Source: Neuroscience News • Published: 13 Oct 2026, 20:03

Summarized by Masters of Longevity from Neuroscience News.

Women s metabolic-reproductive health is examined in a review linking the syndrome to later cognitive and neurodegenerative vulnerability; open this article to understand the scope and implications of that research.

PCOS/PMOS Increases Alzheimer’s Risk
Key Takeaways
  • Women with polyendocrine metabolic ovarian syndrome (PMOS) show mild but reproducible impairments in memory and executive function.
  • The apparent increased Alzheimer’s and dementia risk in PMOS is primarily mediated by chronic insulin resistance and obesity.
  • Proactive metabolic management in early adulthood could reduce long-term neurodegenerative vulnerability in PMOS patients.
Read the full article at Neuroscience News ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?